Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Citrate synthase pseudogene 2 (CSP2) is a genomic element classified as a pseudogene—a DNA sequence resembling the functional citrate synthase gene but generally regarded as non-functional and not transcribed into a protein. Citrate synthase itself is a key enzyme in the citric acid (Krebs) cycle, crucial for energy metabolism in nearly all aerobic tissues[1][3][5][7], but CSP2 does not contribute to this process, nor is it considered a therapeutic target or biomarker. Pseudogenes such as CSP2 may arise from duplication events or retrotransposition but typically lack the elements necessary for protein production, and there is no evidence they play a role in disease or therapeutic responses. This target is not a functional receptor, enzyme, transporter, or therapeutic target. CSP2 is a non-functional pseudogene, not a druggable protein or biomolecule required in a structured target database for therapeutic information. Thus, "is_incorrect" is set to true for inclusion as a drug target.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Citrate synthase pseudogene 2 (CSP2).